Literature DB >> 23818515

The pneumococcus: epidemiology, microbiology, and pathogenesis.

Birgitta Henriques-Normark1, Elaine I Tuomanen.   

Abstract

The pneumococcus is the classic Gram-positive extracellular pathogen. The medical burden of diseases it causes is amongst the greatest in the world. Intense study for more than 100 years has yielded an understanding of fundamental aspects of its physiology, pathogenesis, and immunity. Efforts to control infection have led to the deployment of polysaccharide vaccines and an understanding of antibiotic resistance. The inflammatory response to pneumococci, one of the most potent in medicine, has revealed the double-edged sword of clearance of infection but at a cost of damage to host cells. In virtually every aspect of the infectious process, the pneumococcus has set the rules of the Gram-positive pathogenesis game.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818515      PMCID: PMC3685878          DOI: 10.1101/cshperspect.a010215

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  97 in total

1.  Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model.

Authors:  H H Tong; L E Blue; M A James; T F DeMaria
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Clonal success of piliated penicillin nonsusceptible pneumococci.

Authors:  K Sjöström; C Blomberg; J Fernebro; J Dagerhamn; E Morfeldt; M A Barocchi; S Browall; M Moschioni; M Andersson; F Henriques; B Albiger; Rino Rappuoli; S Normark; B Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-20       Impact factor: 11.205

3.  Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Authors:  Carlos J Orihuela; Jafar Mahdavi; Justin Thornton; Beth Mann; Karl G Wooldridge; Noha Abouseada; Neil J Oldfield; Tim Self; Dlawer A A Ala'Aldeen; Elaine I Tuomanen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

Review 4.  Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region.

Authors:  Tzou-Yien Lin; Nitin K Shah; Dennis Brooks; Carmen S Garcia
Journal:  Vaccine       Date:  2010-08-01       Impact factor: 3.641

5.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

6.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

7.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.

Authors:  Jonathan M Cohen; Suneeta Khandavilli; Emilie Camberlein; Catherine Hyams; Helen E Baxendale; Jeremy S Brown
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Control of virulence by small RNAs in Streptococcus pneumoniae.

Authors:  Beth Mann; Tim van Opijnen; Jianmin Wang; Caroline Obert; Yong-Dong Wang; Robert Carter; Daniel J McGoldrick; Granger Ridout; Andrew Camilli; Elaine I Tuomanen; Jason W Rosch
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

View more
  144 in total

1.  Pneumolysin-Dependent Calpain Activation and Interleukin-1α Secretion in Macrophages Infected with Streptococcus pneumoniae.

Authors:  Rendong Fang; Rui Wu; Huihui Du; Meilan Jin; Yajing Liu; Guihua Lei; Bing Jiang; Zehui Lei; Yuanyi Peng; Kui Nie; Kohsuke Tsuchiya
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.

Authors:  Colin Kietzman; Elaine Tuomanen
Journal:  ACS Infect Dis       Date:  2019-07-03       Impact factor: 5.084

3.  S1 Domain RNA-Binding Protein CvfD Is a New Posttranscriptional Regulator That Mediates Cold Sensitivity, Phosphate Transport, and Virulence in Streptococcus pneumoniae D39.

Authors:  Dhriti Sinha; Jiaqi J Zheng; Ho-Ching Tiffany Tsui; John D Richardson; Nicholas R De Lay; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2020-08-25       Impact factor: 3.490

4.  Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.

Authors:  Ozden Kocaoglu; Ho-Ching T Tsui; Malcolm E Winkler; Erin E Carlson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 5.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

6.  Redefining the Small Regulatory RNA Transcriptome in Streptococcus pneumoniae Serotype 2 Strain D39.

Authors:  Dhriti Sinha; Kurt Zimmer; Todd A Cameron; Douglas B Rusch; Malcolm E Winkler; Nicholas R De Lay
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

Review 7.  Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.

Authors:  Kapil Juvale; Althaf Shaik; Sivapriya Kirubakaran
Journal:  Medchemcomm       Date:  2019-05-02       Impact factor: 3.597

8.  Absence of the KhpA and KhpB (JAG/EloR) RNA-binding proteins suppresses the requirement for PBP2b by overproduction of FtsA in Streptococcus pneumoniae D39.

Authors:  Jiaqi J Zheng; Amilcar J Perez; Ho-Ching Tiffany Tsui; Orietta Massidda; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2017-11-02       Impact factor: 3.501

9.  Plasma Proteome Signature of Sepsis: a Functionally Connected Protein Network.

Authors:  Genaro Pimienta; Douglas M Heithoff; Alexandre Rosa-Campos; Minerva Tran; Jeffrey D Esko; Michael J Mahan; Jamey D Marth; Jeffrey W Smith
Journal:  Proteomics       Date:  2019-02-20       Impact factor: 3.984

10.  Pbp2x localizes separately from Pbp2b and other peptidoglycan synthesis proteins during later stages of cell division of Streptococcus pneumoniae D39.

Authors:  Ho-Ching T Tsui; Michael J Boersma; Stephen A Vella; Ozden Kocaoglu; Erkin Kuru; Julia K Peceny; Erin E Carlson; Michael S VanNieuwenhze; Yves V Brun; Sidney L Shaw; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2014-08-21       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.